Physostegia parviflora
Physostegia parviflora · Accepted scientific name
Scientific literature: Very Sparse (47 studies) · ★☆☆☆☆
Physostegia parviflora, scientifically known as Physostegia parviflora, is a distinctive medicinal herb valued for its therapeutic potential. Often found in specific ecological niches, this plant is recognized in traditional medicine for its unique phytochemical properties, offering promising applications in treating various ailments through its natural bioactive compounds and restorative qualities.
- Family
- Not available
- Native range
- Northern America
- Parts used
- Not available
- Common names
- Not available
- Scientific synonyms
- Not available
Names and Synonyms
Scientific Names
Accepted name
Physostegia parvifloraDistribution
This plant exhibits a specific distribution pattern across Western Canada and the Northwestern United States. In the Canadian provinces, it can be found growing in British Columbia, Manitoba, and Saskatchewan. Its range extends southward into the Northwestern U.S.A. as well. Specifically, the species is documented within the borders of Idaho and Montana. Together, these regions define the primary geographical footprint of Physostegia parviflora.
| Region | Area |
|---|---|
| Western Canada | British Columbia |
| Western Canada | Manitoba |
| Western Canada | Saskatchewan |
| Northwestern U.S.A. | Idaho |
| Northwestern U.S.A. | Montana |
| Northwestern U.S.A. | Oregon |
| Northwestern U.S.A. | Washington |
| Northwestern U.S.A. | Wyoming |
| North-Central U.S.A. | Illinois |
| North-Central U.S.A. | Minnesota |
Sources: The World Checklist of Vascular Plants (WCVP)
Botanical Identification
Life history
The life history of Physostegia parviflora is characterized by its status as a perennial plant, ensuring its persistence across multiple growing seasons. In terms of its structural growth strategy, the species is classified as a hemicryptophyte, meaning its perennable buds are located at or just below the soil surface, protected by leaf litter or debris during unfavorable conditions. This life form, consistent across its biological categorization as a hemicryptophyte, allows the plant to endure seasonal transitions and emerge reliably each year to complete its reproductive cycle.
- Life form :
- hemicryptophyte
- Lifecycle :
- perennial
Morphology
The morphology of Physostegia parviflora is characterized by a growth form classified as both a herb and a forb, exhibiting a non-woody structure throughout its development. As a terrestrial organism, it does not function as an epiphyte or an aquatic/semiaquatic species, nor does it exhibit any parasitic behavior, maintaining an independent life cycle. In terms of its physical habit, the plant acts as a self-supporting climber, categorized as both a facultative and a self-supporting vine or liana, allowing it to navigate its environment without relying on obligatory climbing mechanisms.
- Aquatic :
- terrestrial
- Climber :
- self-supporting
- Epiphyte :
- terrestrial
- Growth form :
- herb
- Growth form :
- forb
- Parasite :
- independent
- Woodiness :
- non-woody
Physiology
The physiology of Physostegia parviflora is characterized by a metabolic framework centered on a C3 photosynthetic pathway, which dictates its carbon fixation processes and gas exchange mechanisms. In this C3 pathway, the initial fixation of atmospheric carbon dioxide occurs through the enzyme Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO), resulting in the direct production of a three-carbon molecule, 3-phosphoglycerate. This metabolic strategy implies that the plant relies on relatively high moisture availability and moderate temperatures to maintain efficient stomatal conductance and minimize photorespiration. The energy conversion process involves a standard light-dependent reaction to generate ATP and NADPH, which are subsequently utilized in the Calvin cycle to synthesize carbohydrates. Consequently, its physiological efficiency is closely tied to the environmental availability of water and light intensity, as it lacks the specialized anatomical adaptations found in C4 or CAM species to mitigate carbon loss under extreme heat or aridity.
- Photosynthetic pathway :
- C3
Reproduction
Reproduction in Physostegia parviflora is characterized by the production of small seeds that exhibit highly uniform physical properties. Based on quantitative data, the seed mass of this species is remarkably consistent, with a mean mass of 0.0019 g. This uniformity is reflected in the absence of variance within the recorded samples, as both the maximum and minimum seed mass values are identical at 0.0019 g. Such precise seed dimensions suggest a stabilized reproductive output, where each individual seed maintains a standardized weight of 0.0019 g, facilitating predictable patterns in dispersal and germination processes.
- Seed mass mean:
- 0.0019 g
Sources: Global Inventory of Floras and Traits (GIFT)
Chemicals
Physostegia parviflora has 5 reported phytochemicals identified across 0 scientific publications and several other databases. The most consistently reported chemicals include Bicyclogermacrene, Caryophyllene, EO, Germacrene D, MYRCENE.
| Chemical | Supporting sources | Consensus |
|---|---|---|
| Bicyclogermacrene | 1 supporting sources | ★☆☆☆☆ |
| Caryophyllene | 1 supporting sources | ★☆☆☆☆ |
| EO | 1 supporting sources | ★☆☆☆☆ |
| Germacrene D | 1 supporting sources | ★☆☆☆☆ |
| MYRCENE | 1 supporting sources | ★☆☆☆☆ |
Bicyclogermacrene
- Dr. Duke
Caryophyllene
- Dr. Duke
EO
- Dr. Duke
Germacrene D
- Dr. Duke
MYRCENE
- Dr. Duke
Activities
Physostegia parviflora has 42 reported activities identified across 0 scientific publications and several other databases. The most consistently reported activities include ACE-Inhibitor, Aldose-Reductase-Inhibitor, Allergenic, Analgesic, Antiacne.
| Activity | Supporting sources | Consensus |
|---|---|---|
| ACE-Inhibitor | 1 supporting sources | ★☆☆☆☆ |
| Aldose-Reductase-Inhibitor | 1 supporting sources | ★☆☆☆☆ |
| Allergenic | 1 supporting sources | ★☆☆☆☆ |
| Analgesic | 1 supporting sources | ★☆☆☆☆ |
| Antiacne | 1 supporting sources | ★☆☆☆☆ |
| Antiasthmatic | 1 supporting sources | ★☆☆☆☆ |
| Antibacterial | 1 supporting sources | ★☆☆☆☆ |
| Anticariogenic | 1 supporting sources | ★☆☆☆☆ |
| Anticonvulsant | 1 supporting sources | ★☆☆☆☆ |
| Antidermatitic | 1 supporting sources | ★☆☆☆☆ |
ACE-Inhibitor
- Dr. Duke
Aldose-Reductase-Inhibitor
- Dr. Duke
Allergenic
- Dr. Duke
Analgesic
- Dr. Duke
Antiacne
- Dr. Duke
Antiasthmatic
- Dr. Duke
Antibacterial
- Dr. Duke
Anticariogenic
- Dr. Duke
Anticonvulsant
- Dr. Duke
Antidermatitic
- Dr. Duke